Suheung Co., Ltd. (KRX:008490)
28,900
-50 (-0.17%)
Last updated: Sep 9, 2025, 9:20 AM KST
Suheung Revenue
Suheung had revenue of 190.02B KRW in the quarter ending June 30, 2025, with 9.99% growth. This brings the company's revenue in the last twelve months to 686.02B, up 10.01% year-over-year. In the year 2024, Suheung had annual revenue of 653.26B with 9.87% growth.
Revenue (ttm)
686.02B
Revenue Growth
+10.01%
P/S Ratio
0.47
Revenue / Employee
924.56M
Employees
742
Market Cap
321.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
Dec 31, 2020 | 553.01B | 92.28B | 20.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |